Trial Profile
Efficacy and safety of combination therapy of vildagliptin and insulin
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Jul 2015
Price :
$35
*
At a glance
- Drugs Vildagliptin (Primary) ; Antihyperglycaemics; Insulin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 08 Jul 2015 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan
- 26 Sep 2013 New trial record